Inhibition of cyclic guanosine 5′-monophosphate-dependent protein kinase I (PKG-I) in lumbar spinal cord reduces formalin-induced hyperalgesia and PKG upregulation

Nitric Oxide - Biology and Chemistry

Volumn 8, Issue 2, 2003, Pages 89-94

  Schmidtko, Achim ^a   Ruth, Peter ^b   Geisslinger, Gerd ^a   Tegeder, Irmgard ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

cGMP; cGMP dependent kinase; Formalin assay; Nociception; Spinal cord

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; CYCLIC GMP DEPENDENT PROTEIN KINASE; CYCLIC GMP DEPENDENT PROTEIN KINASE INHIBITOR; FORMALDEHYDE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; GENE EXPRESSION REGULATION; HYPERALGESIA; LUMBAR SPINAL CORD; MALE; NOCICEPTION; NOCICEPTIVE STIMULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SYNAPTIC TRANSMISSION;

ANIMALIA;

EID: 0037333607     PISSN: 10898603     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1089-8603(02)00165-9     Document Type: Article

References (33)

1. Yaksh T.L., Hua X.Y., Kalcheva I., Nozaki-Taguchi N., Marsala M. The spinal biology in humans and animals of pain states generated by persistent small afferent input. Proc. Natl. Acad. Sci. USA. 96:1999;7680-7686.
2. Vetter G., Geisslinger G., Tegeder I. Release of glutamate, nitric oxide and prostaglandin E(2) and metabolic activity in the spinal cord of rats following peripheral nociceptive stimulation. Pain. 92:2001;213-218.
3. Meller S.T., Cummings C.P., Traub R.J., Gebhart G.F. The role of nitric oxide in the development and maintenance of the hyperalgesia produced by intraplantar injection of carrageenan in the rat. Neuroscience. 60:1994;367-374.
4. Moore P.K., Oluyomi A.O., Babbedge R.C., Wallace P., Hart S.L. L-NG-nitro arginine methyl ester exhibits antinociceptive activity in the mouse. Br. J. Pharmacol. 102:1991;198-202.
5. Malmberg A.B., Yaksh T.L. Spinal nitric oxide synthesis inhibition blocks NMDA-induced thermal hyperalgesia and produces antinociception in the formalin test in rats. Pain. 54:1993;291-300.
6. Aley K.O., McCarter G., Levine J.D. Nitric oxide signaling in pain and nociceptor sensitization in the rat. J. Neurosci. 18:1998;7008-7014.
7. Inoue T., Mashimo T., Shibuta S., Yoshiya I. Intrathecal administration of a new nitric oxide donor, NOC-18, produces acute thermal hyperalgesia in the rat. J. Neurol. Sci. 153:1997;1-7.
8. Jaffrey S.R., Erdjument-Bromage H., Ferris C.D., Tempst P., Snyder S.H. Protein S-nitrosylation: a physiological signal for neuronal nitric oxide. Nat. Cell Biol. 3:2001;193-197.
9. Pieper A.A., Blackshaw S., Clements E.E., Brat D.J., Krug D.K.et al. Poly(ADP-ribosyl)ation basally activated by DNA strand breaks reflects glutamate-nitric oxide neurotransmission. Proc. Natl. Acad. Sci. USA. 97:2000;1845-1850.
10. Southam E., Charles S.L., Garthwaite J. The nitric oxide-cyclic GMP pathway and synaptic plasticity in the rat superior cervical ganglion. Br. J. Pharmacol. 119:1996;527-532.
11. Lewin M.R., Walters E.T. Cyclic GMP pathway is critical for inducing long-term sensitization of nociceptive sensory neurons. Nat. Neurosci. 2:1999;18-23.
12. Ruth P. Cyclic GMP-dependent protein kinases: understanding in vivo functions by gene targeting. Pharmacol. Ther. 82:1999;355-372.
13. Qian Y., Chao D.S., Santillano D.R., Cornwell T.L., Nairn A.C.et al. cGMP-dependent protein kinase in dorsal root ganglion: relationship with nitric oxide synthase and nociceptive neurons. J. Neurosci. 16:1996;3130-3138.
14. Tao Y.X., Hassan A., Haddad E., Johns R.A. Expression and action of cyclic GMP-dependent protein kinase Ialpha in inflammatory hyperalgesia in rat spinal cord. Neuroscience. 95:2000;525-533.
15. Tao Y.X., Hassan A., Johns R.A. Intrathecally administered cGMP-dependent protein kinase Ialpha inhibitor significantly reduced the threshold for isoflurane anesthesia: implication for a novel role of cGMP-dependent protein kinase Ialpha. Anesthesiology. 92:2000;493-499.
16. Tao Y.X., Johns R.A. Activation of cGMP-dependent protein kinase. 1α is required for N-methyl-D-aspartate- or nitric oxide-produced spinal thermal hyperalgesia Eur. J. Pharmacol. 392:2000;141-145.
17. Hartell N.A. cGMP acts within cerebellar Purkinje cells to produce long term depression via mechanisms involving PKC and PKG. Neuroreport. 5:1994;833-836.
18. Calabresi P., Gubellini P., Centonze D., Sancesario G., Morello M.et al. A critical role of the nitric oxide/cGMP pathway in corticostriatal long-term depression. J. Neurosci. 19:1999;2489-2499.
19. Santschi L., Reyes-Harde M., Stanton P.K. Chemically induced, activity-independent LTD elicited by simultaneous activation of PKG and inhibition of PKA. J. Neurophysiol. 82:1999;1577-1589.
20. Zhuo M., Hu Y., Schultz C., Kandel E.R., Hawkins R.D. Role of guanylyl cyclase and cGMP-dependent protein kinase in long-term potentiation. Nature. 368:1994;635-639.
21. ′ -cyclic GMP in cultured hippocampal neurons Nature. 376:1995;74-80.
22. Erb K., Liebel J.T., Tegeder I., Zeilhofer H.U., Brune K.et al. Spinally delivered nociceptin/orphanin FQ reduces flinching behaviour in the rat formalin test. Neuroreport. 8:1997;1967-1970.
23. Sirotkin A.V., Makarevich A.V., Genieser H.G., Kotwica J., Hetenyi L. Effect of four cGMP analogues with different mechanisms of action on hormone release by porcine ovarian granulosa cells in vitro. Exp. Clin. Endocrinol. Diabetes. 108:2000;214-219.
24. Huber A., Neuhuber W.L., Klugbauer N., Ruth P., Allescher H.D. Cysteine-rich protein 2, a novel substrate for cGMP kinase I in enteric neurons and intestinal smooth muscle. J. Biol. Chem. 275:2000;5504-5511.
25. Pfeifer A., Aszodi A., Seidler U., Ruth P., Hofmann F.et al. Intestinal secretory defects and dwarfism in mice lacking cGMP- dependent protein kinase II. Science. 274:1996;2082-2086.
26. Tegeder I., Niederberger E., Vetter G., Brautigam L., Geisslinger G. Effects of selective COX-1 and -2 inhibition on formalin-evoked nociceptive behaviour and prostaglandin E(2) release in the spinal cord. J. Neurochem. 79:2001;777-786.
27. Niederberger E., Tegeder I., Vetter G., Schmidtko A., Schmidt H.et al. Celecoxib loses its anti-inflammatory efficacy at high doses through activation of NF-kappaB. FASEB J. 15:2001;1622-1624.
28. Ji R.R., Baba H., Brenner G.J., Woolf C.J. Nociceptive-specific activation of ERK in spinal neurons contributes to pain hypersensitivity. Nat. Neurosci. 2:1999;1114-1119.
29. Lin Q., Peng Y.B., Wu J., Willis W.D. Involvement of cGMP in nociceptive processing by and sensitization of spinothalamic neurons in primates. J. Neurosci. 17:1997;3293-3302.
30. Ruth P., Wang G.X., Boekhoff I., May B., Pfeifer A.et al. Transfected cGMP-dependent protein kinase suppresses calcium transients by inhibition of inositol 1,4,5-trisphosphate production. Proc. Natl. Acad. Sci. USA. 90:1993;2623-2627.
31. Schlossmann J., Ammendola A., Ashman K., Zong X., Huber A.et al. Regulation of intracellular calcium by a signalling complex of IRAG, IP3 receptor and cGMP kinase Ibeta. Nature. 404:2000;197-201.
32. + currents by cGMP-dependent protein kinase in tracheal smooth muscle and Chinese hamster ovary cells. J. Biol. Chem. 271:1996;19760-19767.
33. Soff G.A., Cornwell T.L., Cundiff D.L., Gately S., Lincoln T.M. Smooth muscle cell expression of type I cyclic GMP-dependent protein kinase is suppressed by continuous exposure to nitrovasodilators, theophylline, cyclic GMP, and cyclic AMP. J. Clin. Invest. 100:1997;2580-2587.